You are Trying to View a Free Article
Daily News You Can't Find Anywhere ElseInstituto Butantan to Produce CoronaVac Vaccine in Brazil, an Industrial Info Market Brief
Industry Segment: Market Brief | Word Count: 99 Words
Brazilian state company Instituto Butantan, with the financial support of Fundacao Butantan, is investing around $31 million at its Sao Paulo plant to produce 1.2 million units of the CoronaVac vaccine for COVID-19.
Subscribe Now! All Fields Required...
Related Articles
- South Korea Hosts More Than $1 Billion Worth of Pharma-Bio Projects, an Ind...
- Iraq's South Refineries Company Expects to Increase Refining Capacity by 70...
- Sichuan Province Leads China in Lithium Compounds Project Spending, an Indu...
- South Korea's Cement, Steel Sectors Invest in Environmental Equipment, an I...
- China Expects $134 Million in Chemical Maintenance Projects in 2021, an Ind...
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker
All Members Receive the Following Free Resources:
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
